Working to meet sponsors' needs in IBD
Clinical trials in Crohn’s disease and ulcerative colitis are at the core of PSI’s expertise.
We're dedicated to delivering trials on time and on budget.
PSI’s key differentiator is our ability to plan and execute complex clinical trials on time, saving our customers millions of development dollars.
PSI’s strength is in its people and their attitude. The PSI management team that founded the company 20+ years ago is still here and fully engaged in day-to-day project life. “Navy seals of the CRO industry” was how one of our clients described PSI.
Our mission is to be the best CRO in the world as measured by our clients and our employees. With 2,000 folks in 59 countries we have a lot of talent to look after. Dozens of customers in
a variety of therapeutic areas have come to PSI and stayed. Maybe that is why after 20+ years in the industry PSI still enjoys a solid reputation and grows mainly through repeat and referral business.
When combined, these characteristics yield tangible outcomes for our customers. Studies run on time and on budget and save hundreds of millions of development dollars.
“One of the most seamless partnerships between a sponsor and a CRO that I have ever seen.” VP Global Clinical Operations